Scientists at USC Dornsife and the USC Michelson Center for Convergent Bioscience are hoping to spark drug research across the university by hosting a series of workshops starting Friday.
The grand opening ceremonies celebrate the latest cutting-edge facilities at the center, which brings together researchers from the university’s engineering and medical schools and the USC Dornsife College of Letters, Arts and Sciences.
Peter Kuhn of the USC Michelson Center for Convergent Bioscience will serve as deputy director of a new virtual cancer center, funded by a grant from the Department of Defense.
Dedicated space for the Convergent Science Institute in Cancer initiative aims to get biologists, physicists and chemists collaborating on cutting-edge ideas that benefit patients.
A USC-led team has developed advanced imaging techniques that allow for a uniquely detailed glimpse inside the body’s insulin factories.
USC grads Kyle McClary and John Paul Francis are bringing imaging technology out of the lab and onto researchers’ laptops and cellphones.
The findings from USC researchers provide a clear path to uncovering new drugs to control addiction, pain and neurological disorders such as epilepsy and muscle spasticity.
The decorated USC professor received an award from the Society for Research on Biological Rhythms for decades of research into the mustard plant.
A clash between modern lifestyles and circadian rhythms can lead to the development of obesity and breast cancer, USC scientist says
Scientists at the USC Michelson Center for Convergent Bioscience and Stanford University take first step toward a safer drug for reducing postpartum bleeding.
